SVE Fundamental Analysis - SHAREHOLDER VALUE BET AG

Fundamental Rating

Taking everything into account, SVE scores 4 out of 10 in our fundamental rating. SVE was compared to 121 industry peers in the Capital Markets industry. SVE has a great financial health rating, but its profitability evaluates not so good. SVE is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SVE has reported negative net income.
In multiple years SVE reported negative net income over the last 5 years.
SVE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

SVE has a Return On Assets of -11.09%. This is in the lower half of the industry: SVE underperforms 70.25% of its industry peers.
SVE has a worse Return On Equity (-11.09%) than 67.77% of its industry peers.
SVE has a better Return On Invested Capital (10.25%) than 85.12% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SVE is below the industry average of 8.43%.
The last Return On Invested Capital (10.25%) for SVE is above the 3 year average (4.04%), which is a sign of increasing profitability.

		Industry Rank	Sector Rank
ROA	-11.09%
ROE	-11.09%
ROIC	10.25%

ROA(3y)-13.98%

ROA(5y)-0.33%

ROE(3y)-14.19%

ROE(5y)-0.45%

ROIC(3y)4.04%

ROIC(5y)9.43%

1.3 Margins

SVE has a better Operating Margin (40.16%) than 80.99% of its industry peers.
SVE's Operating Margin has declined in the last couple of years.
SVE has a better Gross Margin (42.08%) than 64.46% of its industry peers.
SVE's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	40.16%
PM (TTM)	N/A
GM	42.08%

OM growth 3Y-32.43%

OM growth 5Y-24.84%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-22.8%

GM growth 5Y-14.89%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SVE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SVE has less shares outstanding
SVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

SVE has an Altman-Z score of 243.54. This indicates that SVE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 243.54, SVE belongs to the best of the industry, outperforming 99.17% of the companies in the same industry.
There is no outstanding debt for SVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	243.54

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 76.50 indicates that SVE has no problem at all paying its short term obligations.
SVE has a better Current ratio (76.50) than 98.35% of its industry peers.
SVE has a Quick Ratio of 76.50. This indicates that SVE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 76.50, SVE belongs to the best of the industry, outperforming 98.35% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	76.5
Quick Ratio	76.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.26%, which is quite impressive.
Looking at the last year, SVE shows a very negative growth in Revenue. The Revenue has decreased by -83.41% in the last year.
SVE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.37% yearly.

EPS 1Y (TTM)46.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%592.9%

Revenue 1Y (TTM)-83.41%

Revenue growth 3Y-36.39%

Revenue growth 5Y9.37%

Sales Q2Q%478.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SVE!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

SHAREHOLDER VALUE BET AG

FRA:SVE (1/20/2026, 7:00:00 PM)

80.5

-1 (-1.23%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.11%

Inst Owner ChangeN/A

Ins Owners0.86%

Ins Owner ChangeN/A

Market Cap56.35M

Revenue(TTM)25.00M

Net Income(TTM)-7.65M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.25
P/FCF	N/A
P/OCF	N/A
P/B	0.82
P/tB	0.82
EV/EBITDA	N/A

EPS(TTM)-10.93

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS35.71

BVpS98.37

TBVpS98.37

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-11.09%
ROE	-11.09%
ROCE	14.56%
ROIC	10.25%
ROICexc	10.25%
ROICexgc	10.25%
OM	40.16%
PM (TTM)	N/A
GM	42.08%
FCFM	N/A

ROA(3y)-13.98%

ROA(5y)-0.33%

ROE(3y)-14.19%

ROE(5y)-0.45%

ROIC(3y)4.04%

ROIC(5y)9.43%

ROICexc(3y)4.07%

ROICexc(5y)12.54%

ROICexgc(3y)4.07%

ROICexgc(5y)12.54%

ROCE(3y)5.73%

ROCE(5y)13.39%

ROICexgc growth 3Y-57.23%

ROICexgc growth 5Y-20.87%

ROICexc growth 3Y-57.23%

ROICexc growth 5Y-20.87%

OM growth 3Y-32.43%

OM growth 5Y-24.84%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-22.8%

GM growth 5Y-14.89%

F-ScoreN/A

Asset Turnover0.36

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	76.5
Quick Ratio	76.5
Altman-Z	243.54

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)46.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%592.9%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-83.41%

Revenue growth 3Y-36.39%

Revenue growth 5Y9.37%

Sales Q2Q%478.27%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y114.62%

EBIT growth 3Y-57.02%

EBIT growth 5Y-17.8%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

SHAREHOLDER VALUE BET AG / SVE.DE FAQ

What is the ChartMill fundamental rating of SHAREHOLDER VALUE BET AG (SVE.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SVE.DE.

What is the valuation status for SVE stock?

ChartMill assigns a valuation rating of 0 / 10 to SHAREHOLDER VALUE BET AG (SVE.DE). This can be considered as Overvalued.

What is the profitability of SVE stock?

SHAREHOLDER VALUE BET AG (SVE.DE) has a profitability rating of 3 / 10.

How financially healthy is SHAREHOLDER VALUE BET AG?

The financial health rating of SHAREHOLDER VALUE BET AG (SVE.DE) is 9 / 10.

SHAREHOLDER VALUE BET AG (SVE.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SHAREHOLDER VALUE BET AG / SVE.DE FAQ

What is the ChartMill fundamental rating of SHAREHOLDER VALUE BET AG (SVE.DE) stock?

What is the valuation status for SVE stock?

What is the profitability of SVE stock?

How financially healthy is SHAREHOLDER VALUE BET AG?